全球生物安全檢測產品和服務市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計生物安全檢測產品和服務的市場規模將從 2025 年的 62.3 億美元成長到 2034 年的 158.9 億美元，2026 年至 2034 年的複合年成長率為 10.97%。

對安全生物製藥和疫苗日益成長的需求正推動全球生物安全檢測產品和服務市場顯著成長。監管機構要求對包括疫苗、細胞療法和單株抗體在內的生物製藥進行嚴格的安全檢測，這促進了先進檢測服務和產品的應用。生物技術領域研究活動的增加和製藥生產設施的擴張也進一步支撐了市場成長。

此外，全球生物製藥和生物相似藥研發管線的不斷成長也為市場發展提供了利好。隨著越來越多的生物製藥進入臨床試驗，對污染檢測、內毒素檢測和無菌檢測的需求日益成長。快速微生物檢測方法和自動化檢測解決方案的技術進步正在提高檢測的準確性和效率。製藥和生物技術公司正在加速採用創新檢測平台，以確保產品品質和符合法規要求。

展望未來，隨著生物製藥和先進治療方法繼續主導製藥業，市場預計將保持強勁成長。受託研究機構（CRO）和實驗室的擴張將進一步加速外包趨勢。此外，新興市場對製藥生產基礎設施的投資增加，也為生物安全檢測服務創造了新的機會。檢測技術的持續創新和嚴格的監管標準將繼續成為影響未來成長的關鍵因素。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球生物安全檢測產品與服務市場：依產品類別分類

• 市場分析、洞察與預測
• 試劑和試劑盒
• 裝置
• 服務

第5章 全球生物安全檢測產品與服務市場：依應用領域分類

• 市場分析、洞察與預測
• 疫苗及治療藥物（疫苗、單株抗體、重組蛋白）
• 血液及血液製品
• 基因治療
• 組織和源自組織的商品
• 幹細胞

第6章 全球生物安全檢測產品與服務市場：依檢測類型分類

• 市場分析、洞察與預測
• 內毒素試驗
• 無菌測試
• 細胞株認證和表徵測試
• 微生物附著量測試
• 異物檢測測試
• 殘留宿主污染檢測
• 其他

第7章 全球生物安全檢測產品與服務市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Charles River Laboratories International
  • BSL Bioservice GmbH
  • Merck KGaA（MilliporeSigma）
  • Samsung Biologics Co. Ltd
  • Sartorius AG
  • Eurofins Scientific SE
  • SGS SociAfA（C）TAfA（C）GAfA（C）NAfA（C）Rale De Surveillance SA
  • Thermo Fisher Scientific Inc
  • BioMAfA（C）Rieux SA
  • Lonza Group AG

The Biological Safety Testing Products And Services Market size is expected to reach USD 15.89 Billion in 2034 from USD 6.23 Billion (2025) growing at a CAGR of 10.97% during 2026-2034.

The global biological safety testing products and services market is experiencing significant growth due to the rising demand for safe biopharmaceutical products and vaccines. Regulatory authorities require strict safety testing for biologics, including vaccines, cell therapies, and monoclonal antibodies, which is driving the adoption of advanced testing services and products. Increasing research activities in biotechnology and the expansion of pharmaceutical manufacturing facilities are further supporting market expansion.

The market is also benefiting from the growing pipeline of biologics and biosimilars worldwide. As the number of biologic drugs entering clinical trials increases, the need for contamination testing, endotoxin testing, and sterility testing is rising. Technological advancements in rapid microbiological methods and automated testing solutions are improving testing accuracy and efficiency. Pharmaceutical and biotechnology companies are increasingly adopting innovative testing platforms to ensure product quality and regulatory compliance.

Looking ahead, the market is expected to witness robust growth as biologics and advanced therapies continue to dominate the pharmaceutical landscape. The expansion of contract research organizations and testing laboratories will further boost outsourcing trends. Moreover, emerging markets are investing heavily in pharmaceutical manufacturing infrastructure, creating new opportunities for biological safety testing services. Continuous innovation in testing technologies and stringent regulatory standards will remain key factors shaping future growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Reagents & Kits
• Instruments
• Services

By Application

• Vaccines & Therapeutics (Vaccines, Monoclonal Antibodies, Recombinant Protein)
• Blood & Blood-Based Products
• Gene Therapy
• Tissue & Tissue-Based Products
• Stem Cell

By Test Type

• Endotoxin Tests
• Sterility Tests
• Cell Line Authentication & Characterization Tests
• Bioburden Tests
• Adventitious Agent Detection Tests
• Residual Host Contamination Detection Tests
• Others

COMPANIES PROFILED

• Charles River Laboratories International, BSL Bioservice GmbH, Merck KGaA MilliporeSigma, Samsung Biologics Co Ltd, Sartorius AG, Eurofins Scientific SE, SGS Socit Gnrale de Surveillance SA, Thermo Fisher Scientific Inc, bioMrieux SA, Lonza Group AG
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Reagents & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Vaccines & Therapeutics (Vaccines, Monoclonal Antibodies, Recombinant Protein) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Blood & Blood-Based Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Gene Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Tissue & Tissue-Based Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Stem Cell Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Test Type
• 6.2. Endotoxin Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Sterility Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Cell Line Authentication & Characterization Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Bioburden Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Adventitious Agent Detection Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Residual Host Contamination Detection Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By Test Type
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By Test Type
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By Test Type
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By Test Type
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By Test Type
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Charles River Laboratories International
  • 9.2.2 BSL Bioservice GmbH
  • 9.2.3 Merck KGaA (MilliporeSigma)
  • 9.2.4 Samsung Biologics Co. Ltd
  • 9.2.5 Sartorius AG
  • 9.2.6 Eurofins Scientific SE
  • 9.2.7 SGS SociAfA(C)TAfA(C) GAfA(C)NAfA(C)Rale De Surveillance SA
  • 9.2.8 Thermo Fisher Scientific Inc
  • 9.2.9 BioMAfA(C)Rieux SA
  • 9.2.10 Lonza Group AG